A group of researchers recently published a paper in the MDPI journal pharmaceutics that demonstrated the effectiveness of using lipid-biopolymer nanobeads as indomethacin (INDO) carriers to reduce drug toxicity.
Background
INDO, an orally administered non-steroidal anti-inflammatory (NSAID) agent, is used extensively for inflammation, fever, and pain control. However, the oral administration of INDO often leads to severe side effects, specifically in the gastrointestinal system, such as abdominal ache, indigestion, and diarrhea owing to the first-pass metabolism. Thus, new approaches are being investigated to lessen the INDO systemic toxicity and improve its overall efficacy.
Figure 1. Long-term stability of NLC formulations, monitored in terms of size (A), PDI (B), Zeta potential (C) and pH (D) values for up to a year, at 25 °C (n = 3; p < 0.05). © Bonetti, F.M.R., de Paula, E., Fonseca, B.B. et al. (2022)
Colloidal drug delivery systems (DDS) with improved therapeutic actions can reduce the side effects by releasing the loaded drugs in a sustained manner. For instance, nanostructured lipid carriers (NLC) can be used to load and deliver various anti-inflammatory compounds through several drug administration routes. However, NLC as a colloid cannot provide the mucoadhesion and gastro-resistance required for oral administration of INDO.
Lipid–polymer nanohybrid formulations that contain at least a single nanostructured material in their composition can potentially merge the benefits of every excipient/carrier within a single DDS. Biopolymers are widely utilized as DDS as they are biodegradable, biocompatible, and versatile in nature. For instance, chitosan, a cationic polysaccharide, possesses exceptional mucoadhesive properties, which can be suitable for INDO administration.
However, chitosan displays sensitivity to acid media such as the gastric microenvironment. This issue can be resolved using xanthan gum (XAN), an anionic exopolysaccharide, as the coating agent of the lipid-polymer nanohybrid formulations such as nanobeads.
The Study
In this study, researchers combined two distinct strategies of coating and hybridization to decrease the INDO systemic toxicity and extend its release profile by simulating an oral administration. Initially, lipid–biopolymer nanobeads were synthesized in which NLC blended with chitosan solution encapsulated the INDO, and the nanobeads were coated by XAN. Later, they investigated the efficacy of the synthesized nanobeads and the reduction in INDO toxicity due to them.
Figure 2. Digital photo (left) of hybrid nanobeads (XAN@CHT/NLC-INDO) and particle size distribution (right), estimated by ImageJ software, (n = 3). © Bonetti, F.M.R., de Paula, E., Fonseca, B.B. et al. (2022)
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), chitosan, XAN, INDO, Pluronic® 68 (P68), poloxamer, myristyl myristate (MM), coconut oil (CO), and deionized (DI) water with 18 MΩ resistivity were used as the starting materials.
2%, w/v NLC/INDO and NLC as control formulation were synthesized by the ultrasonication emulsification method, where MM acted as a solid lipid, poloxamer as a surfactant, and CO as a liquid lipid. Under magnetic stirring, the lipid phase containing CO and MM was briefly heated without or with 2% INDO at 10oC above the solid lipid melting point.
The aqueous phase containing 2-5% P68 was also heated at a similar temperature and then added to the lipid phase under high-speed homogenization for 3 min at 10,000 rpm in an Ultra-Turrax blender. Eventually, the obtained microemulsion was tip-sonicated at 20 kHz and 500 W in 30 s (on/off) cycles for 20 min, and then cooled in an ice bath to 25oC.
The polydispersity index (PDI) and particle size of the synthesized NLC/INDO and NLC formulations were determined using the dynamic light scattering (DLS) method, while the Zetasizer Nano ZS90 equipment was employed to measure their zeta potential values by electrophoretic light scattering. Researchers also determined the long-term physicochemical stability and in vitro cell viability of the samples and the INDO encapsulation efficiency.
Chitosan was scattered in 50 mL of 0.1% acetic acid, and XAN was dissolved in 50 mL DI water under magnetic stirring. Subsequently, 2% hydroalcoholic INDO solution was mixed with the chitosan solution and stirred at room temperature for 2 h to obtain chitosan/INDO beads.
In the preparation of chitosan/NLC-INDO hybrid nanobeads, half of the acetic acid solution was replaced with NLC loaded with 2% INDO for chitosan solubilization. The final XAN-coated forms were synthesized by initially immersing the aliquots of chitosan/NLC-INDO nanobeads and chitosan/INDO beads into 0.5% w/v XAN aqueous solution, then filtering and cooling them to −20oC, and finally freeze-drying.
Researchers performed the water uptake test and the INDO release test in in vitro mode, and in vivo toxicity assays through the chicken embryo model on the samples.
Observations
Ten distinct NLC formulations without and with INDO were successfully synthesized that showed a pale white color and a homogenous aspect. The physicochemical properties of NLC formulations remained suitable for use even after one year of storage, which indicated their long-term stability, and their INDO encapsulation efficiency was 99%.
The hybrid nanobeads of XAN-coated chitosan and NLC/INDO displayed exceptional thermodynamic, structural, and in vitro swelling properties, which indicated excellent compatibility between the biomaterials, and an extended drug release profile up to 26 hours.
Figure 3. Indomethacin in vitro release from beads (CHT/INDO and XAN@CHT/INDO) and nanobeads (CHT/NLC-INDO and XAN@CHT/NLC-INDO), quantified by UV-vis (λ = 210 nm) at 37 °C, n = 5. © Bonetti, F.M.R., de Paula, E., Fonseca, B.B. et al. (2022)
The synergism observed between the biopolymer and nanolipid excipients helped in preventing the burst release effect within the first two hours of experiments, which simulated a gastric medium, followed by an extended-release in the pH 6.8, simulating an intestinal medium.
The XAN coating on nanobeads acted as a gastro-resistant excipient that protected chitosan and NLC/INDO from an unexpected swelling and prevented drug release in the initial hours of experiments.
The safety of the nanobeads was confirmed in the in vivo toxicity assay in chicken embryos (CE) as the combined benefits of coating and hybridization procedures reduced the inherent toxicity of INDO in chicken embryos.
Taken together, the findings of this study demonstrated that the lipid–biopolymer nanobead can be effectively used for delivering INDO, and other anti-inflammatories, through oral administration.
News
Common Medication Could Save Half a Million Lives Each Year – So Why Isn’t It?
A recent study conducted by scientists at the University of Southern California sheds light on the reasons why children are not receiving an affordable and effective diarrhea treatment. Medical professionals in developing nations are [...]
X Marks the Spot: AI’s Treasure Maps Lead to Early Disease Detection
Medical diagnostics expert, doctor’s assistant, and cartographer are all fair titles for an artificial intelligence model developed by researchers at the Beckman Institute for Advanced Science and Technology. Their new model accurately identifies tumors [...]
Scientists Discover Method To Identify Alzheimer’s Disease Before It Progresses to Dementia
Researchers at Aarhus University have discovered a method to identify Alzheimer’s disease before it progresses to dementia, potentially opening up new avenues for treatment. A groundbreaking study could pave the way for early detection [...]
Startling Discovery: COVID-19 Virus Can Stay in the Body More Than a Year After Infection
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential [...]
New bioengineered protein design shows promise in fighting COVID-19
In the wake of the COVID-19 pandemic, scientists have been racing to develop effective treatments and preventatives against the virus. A recent scientific breakthrough has emerged from the work of researchers aiming to combat [...]
Sugar-coated gold nanoparticles can quickly eliminate bacterial infections, no antibiotics required
If left to their own devices, bacteria on our teeth or wounded skin can encase themselves in a slimy scaffolding, turning into what is called biofilm. These bacteria wreak havoc on our tissue and, [...]
Liquid Lightning: Nanotechnology Unlocks New Energy
EPFL researchers have discovered that nanoscale devices harnessing the hydroelectric effect can harvest electricity from the evaporation of fluids with higher ion concentrations than purified water, revealing a vast untapped energy potential. Evaporation is a natural [...]
Unmasking the Illusion: AI-Generated Faces Challenge Perceptions
Research shows survey participants duped by AI-generated images nearly 40 percent of the time. If you recently had trouble figuring out if an image of a person is real or generated through artificial intelligence [...]
New Discovery Reveals How Cells Defend Themselves During Stressful Situations
Stress granules play a crucial role in the stress response, arising from the aggregation of non-translating mRNAs and proteins. Although significant knowledge exists about stress granules, the mechanisms behind their mRNA localization remain partially [...]
Scientists use a new type of nanoparticle that can both deliver vaccines and act as an adjuvant
Many vaccines, including vaccines for hepatitis B and whooping cough, consist of fragments of viral or bacterial proteins. These vaccines often include other molecules called adjuvants, which help to boost the immune system's response [...]
Not Science Fiction: How Optical Neural Networks Are Revolutionizing AI
A novel architecture for optical neural networks utilizes wavefront shaping to precisely manipulate the travel of ultrashort pulses through multimode fibers, enabling nonlinear optical computation. Present-day artificial intelligence systems rely on billions of adjustable [...]
Turning skin cells into limb cells sets the stage for regenerative therapy
In a collaborative study, researchers from Kyushu University and Harvard Medical School have identified proteins that can turn or “reprogram” fibroblasts — the most commonly found cells in skin and connective tissue — into [...]
AI reveals prostate cancer is not just one disease
Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer, which could revolutionise how the disease is diagnosed and treated in the future. A Cancer Research UK-funded study, published in Cell Genomics, has revealed [...]
New Study Finds That Persistent COVID-19 Infections Are Surprisingly Common
Recent research conducted by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published in the journal Nature. [...]
Innovative nanosheet method revolutionizes brain imaging for multi-scale and long-term studies
The human brain has billions of neurons. Working together, they enable higher-order brain functions such as cognition and complex behaviors. To study these higher-order brain functions, it is important to understand how neural activity [...]
Scientists Have Discovered a Potential Universal Antivenom
Scientists at Scripps Research identified antibodies that protect against a host of lethal snake venoms. Scripps Research scientists have developed an antibody that can block the effects of lethal toxins in the venoms of [...]